ArticleDiscover nano2025
Surface modifications of superparamagnetic iron oxide nanoparticles with citric acid, selenium, and silver combining with polymer blend as antibacterial agent.
Article in Discover nano, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Effects of pristine and citrate-coated zinc oxide nanoparticles on soil nitrogen cycling determined using multi-level assessment of enzyme activity, functional gene abundance and microbial community composition.Environmental science and pollution research international · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antibiotic resistance is a growing global health crisis. This study introduces a novel nanocomposite material incorporating superparamagnetic iron oxide nanoparticles (SPION), citric acid (CA), selenium (Se), silver (Ag), and a polymer matrix (M8) consisting of polyethylene glycol, polyvinylpyrrolidone, chitosan, and polyvinyl alcohol. The novel materials were used to inhibit Pseudomonas aeruginosa (PA), Staphylococcus aureus (SA), and Salmonella enterica (SE). The optimal molar ratio of SPION:CA: CSPION:Se: CSPION/Se/Ag was 1:2:0.5, yielding nanoparticles with an average size of 15.09 ± 2.95 nm (FE-SEM) and a saturation magnetization of 21.51 emu/g (VSM). XRD confirmed the coexistence of Fe₃O₄, Se, and Ag crystalline phases, while FTIR revealed ionic and hydrogen bonding interactions between the polymers, citric acid, and metal nanoparticles. EDS analysis validated the successful incorporation of Se (7.06 wt%) and Ag (22.00 wt%). At this ratio, the inhibition percentage against PA, SA, and SE (using the minimum inhibitory concentration method) at 50% dilution is 99.99 ± 0.52%, 99.31 ± 2.74%, and 47.41 ± 3.69%, respectively. The superior performance is attributed to synergistic effects between SPION, Se, Ag, and the polymer blend, offering a promising approach for combating antibiotic-resistant bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.